Medicare Enrolled
Dr. Jasmin Desai, M.D.
Hematology · Brooksville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Jasmin Desai is a hematology specialist in Brooksville, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 45,161 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Desai received a total of $6,095 from 72 pharmaceutical and/or device companies across 313 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ 45,161 Medicare services
$6,095 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 135699 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗45,161
Medicare services
Bottom 35% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
33,000 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 4,680 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
856 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
760 | $6 | $23 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
603 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
579 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 530 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
391 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 340 | $0 | $9 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
267 | $1 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $93 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $61 | $239 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
168 | $47 | $189 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
134 | $11 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
110 | $96 | $378 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
96 | $27 | $156 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $7 | $69 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
83 | $9 | $42 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
79 | $22 | $84 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
49 | $2 | $7 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
43 | $18 | $59 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $122 | $453 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
40 | $131 | $474 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
37 | $22 | $156 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
32 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
27 | $49 | $178 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
25 | $2 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
25 | $16 | $56 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
21 | $1 | $7 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $103 | $377 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
17 | $5 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $114 | $556 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
15 | $3 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.1% high complexity
94.8% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,095
Total received (2018-2024)
Avg $871/year across 7 years
Bottom 44% in FL for hematology
72
Companies
313
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,989
2023
$1,695
2022
$1,051
2021
$559
2020
$639
2019
$28
2018
$133
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$247
PFIZER INC.
$220
Tempus AI, Inc
$127
Celgene Corporation
$118
EMD Serono, Inc.
$117
GENZYME CORPORATION
$106
Gilead Sciences, Inc.
$88
Merck Sharp & Dohme LLC
$84
Eisai Inc.
$75
ARRAY BIOPHARMA INC
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Lilly USA, LLC
$54
Fennec Pharmaceuticals, Inc.
$52
Janssen Biotech, Inc.
$50
Astellas Pharma US Inc
$46
GlaxoSmithKline, LLC.
$45
Daiichi Sankyo Inc.
$43
Karyopharm Therapeutics Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$33
E.R. Squibb & Sons, L.L.C.
$33
AstraZeneca Pharmaceuticals LP
$31
Incyte Corporation
$30
Kite Pharma, Inc.
$29
Stemline Therapeutics Inc.
$28
SpringWorks Therapeutics, Inc.
$26
Rigel Pharmaceuticals, Inc.
$23
Azurity Pharmaceuticals, Inc.
$23
Pharmacosmos Therapeutics Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
ABBVIE INC.
$18
TAIHO ONCOLOGY, INC.
$16
Agios Pharmaceuticals, Inc.
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Top 3 companies account for 29.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$538
PFIZER INC.
$352
Celgene Corporation
$343
Merck Sharp & Dohme LLC
$236
Gilead Sciences, Inc.
$208
Janssen Biotech, Inc.
$202
Seagen Inc.
$199
Incyte Corporation
$183
E.R. Squibb & Sons, L.L.C.
$182
Eisai Inc.
$179
GENZYME CORPORATION
$179
AstraZeneca Pharmaceuticals LP
$159
Lilly USA, LLC
$159
EMD Serono, Inc.
$154
Genentech USA, Inc.
$140
Daiichi Sankyo Inc.
$135
Tempus AI, Inc
$127
Karyopharm Therapeutics Inc.
$121
GlaxoSmithKline, LLC.
$114
Merck Sharp & Dohme Corporation
$108
Astellas Pharma US Inc
$106
Amgen Inc.
$100
Rigel Pharmaceuticals, Inc.
$100
Ipsen Biopharmaceuticals, Inc
$92
PORTOLA PHARMACEUTICALS, INC.
$89
Regeneron Healthcare Solutions, Inc.
$85
ARRAY BIOPHARMA INC
$85
Kite Pharma, Inc.
$85
Stemline Therapeutics Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Octapharma USA, Inc.
$68
Pharmacyclics LLC, An AbbVie Company
$62
EISAI INC.
$60
Agios Pharmaceuticals, Inc.
$57
Fennec Pharmaceuticals, Inc.
$52
Mirati Therapeutics, Inc.
$49
Dova Pharmaceuticals
$39
Myriad Genetic Laboratories, Inc.
$37
Sobi, Inc
$36
AVEO Pharmaceuticals, Inc.
$36
PUMA BIOTECHNOLOGY, INC.
$35
G1 Therapeutics, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Medtronic, Inc.
$33
CTI BioPharma Corp.
$30
BeiGene USA, Inc.
$27
SpringWorks Therapeutics, Inc.
$26
Axonics, Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$24
GE HealthCare
$23
Azurity Pharmaceuticals, Inc.
$23
Adaptive Biotechnologies Corporation
$22
Exelixis Inc.
$21
CSL Behring
$21
Pharmacosmos Therapeutics Inc.
$19
MorphoSys, US Inc.
$19
Jazz Pharmaceuticals Inc.
$19
SOBI, INC
$19
Deciphera Pharmaceuticals Inc.
$19
ABBVIE INC.
$18
Sumitomo Pharma America, Inc.
$17
MACROGENICS, INC.
$17
Alnylam Pharmaceuticals Inc.
$17
Myovant Sciences Inc.
$17
TAIHO ONCOLOGY, INC.
$16
Puma Biotechnology, Inc.
$16
Heron Therapeutics, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$15
Clovis Oncology, Inc.
$15
NOVARTIS PHARMACEUTICALS CORPORATION
$15
Kyowa Kirin, Inc.
$14
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ANDEXXA · AUGTYRO · Alecensa · Avastin · Axonics r-SNM System · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELREXFIO · ENHERTU · ENJAYMO · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · INTELLIS ADAPTIVESTIM · Idelvion · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONJUVI · MYRISK · NERLYNX · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PLUVICTO · POLIVY · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · VERZENIO · VIVIMUSTA · VOTRIENT · Vanflyta · Venclexta · Vonjo · XALKORI · XGEVA · XPOVIO · XT CDX · XTANDI · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
11
County median income
$63,193
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA OAK HILL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Desai performed 33,000 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $6,095 from 72 companies across 313 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other hematologists in Brooksville?
Dr. Desai's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Brooksville
Browse hematologists in Brooksville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology